GVAX pancreatic cancer vaccine gains FDA orphan-drug status

03/16/2010 | Reuters

GVAX, a pancreatic cancer vaccine from BioSante Pharmaceuticals, received orphan-drug designation from the FDA. The vaccine was developed by Cell Genesys, which was purchased by BioSante last year.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC